Date | Title | Description | Source |
10.04.2024 | Voting Rights and Shares Capital of the Company | In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul... | einpresswi... |
10.04.2024 | Information mensuelle relative au nombre total de droits de ... | Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorit... | einpresswi... |
06.03.2024 | Nanobiotix to Present at Upcoming Investor Conferences in Ma... | - | globenewsw... |
31.01.2024 | Nanobiotix to Present at the Guggenheim 6th Annual Biotechno... | PARIS and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: ... | einpresswi... |
31.01.2024 | Nanobiotix participera à la 6ème conférence annuelle de Biot... | PARIS and CAMBRIDGE, Mass., 31 janv. 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ ... | einpresswi... |
11.01.2024 | Voting Rights and Shares Capital of the Company | In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul... | einpresswi... |
11.01.2024 | INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE ... | Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorit... | einpresswi... |
04.12.2023 | Nanobiotix Announces Closing of the Remaining $4.8 Million I... | - | globenewsw... |
02.11.2023 | NANOBIOTIX Announces Pricing of a Capital Increase Raising T... | - | globenewsw... |
20.07.2023 | Voting Rights and Shares Capital of the Company | /EIN News/ -- In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the... | einpresswi... |
08.06.2023 | Voting Rights and Shares Capital of the Company | /EIN News/ -- In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the... | einpresswi... |
17.04.2023 | NANOBIOTIX to Provide Operational Update and Report Full Yea... | /EIN News/ -- Conference Call and Webcast to be Held at 2:00 PM CEST/8:00 AM EDT on April 25, 2023
P... | einpresswi... |
11.01.2023 | Voting Rights and Shares Capital of the Company | In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul... | einpresswi... |
10.11.2022 | NANOBIOTIX Reports Updated Phase 1 Anti-PD-1 Combination Dat... | Data to be discussed during Nanobiotix Q3 Earnings Call at 8:00AM EST Data show that radiotherapy-ac... | einpresswi... |
31.10.2022 | NANOBIOTIX to Present at the Jefferies London Healthcare Con... | /EIN News/ -- PARIS and Cambridge, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : N... | einpresswi... |
27.10.2022 | NANOBIOTIX annoncera le 9 novembre 2022, ses resultats finan... | PARIS et CAMBRIDGE, Mass., 27 oct. 2022 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO – NASDAQ : N... | globenewsw... |
27.10.2022 | NANOBIOTIX to Announce Third Quarter 2022 Financial Results ... | PARIS and CAMBRIDGE, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: ... | globenewsw... |
18.10.2022 | NANOBIOTIX Executes Definitive Agreement to Restructure Exis... | PARIS and CAMBRIDGE, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: ... | globenewsw... |
18.10.2022 | NANOBIOTIX conclut un accord définitif pour la restructurati... | PARIS et CAMBRIDGE, Mass., 18 oct. 2022 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : ... | globenewsw... |
10.01.2022 | NANOBIOTIX : Provides Corporate Update and Highlights Key 20... | NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
Evaluation of NBTXR3 ... | marketscre... |
20.05.2021 | NANOBIOTIX
Nanobiotix : Announces Updated Results From Prio... | PRESS RELEASE
NANOBIOTIX ANNOUNCES UPDATED RESULTS FROM PRIORITY PATHWAYS IN HEAD AND NECK CANCER AN... | marketscre... |
29.04.2021 | Nanobiotix : Rapport sur les comptes annuels - AGM 2021 | GRANT THORNTON ERNST & YOUNG et Autres
French member of Grant Thornton International
This is a t... | marketscre... |
12.04.2021 | NANOBIOTIX
Nanobiotix : Depositary's Notice of Combined Gen... | Time Sensitive
Materials
Depositary's Notice of
Combined General Meeting
of
Nanobiotix S.A.
ADSs: Am... | marketscre... |
12.04.2021 | NANOBIOTIX
Nanobiotix : Voting Instruction - AGM 2021 | Combined General Meeting
The Voting Instructions must be signed, completed and received at the indic... | marketscre... |
08.04.2021 | Nanobiotix : Amendment to Annual Report by Foreign Issuer (S... | nbx-20201231
_______________________________________________________________________________________... | marketscre... |
08.04.2021 | NANOBIOTIX
Nanobiotix : Amendment to Annual Report by Forei... | nbx-20201231
_______________________________________________________________________________________... | marketscre... |
07.04.2021 | Nanobiotix : Rapport sur les comptes consolidés - AGM 2021 | GRANT THORNTON ERNST & YOUNG et Autres
French member of Grant Thornton International
This is a t... | marketscre... |
07.04.2021 | Nanobiotix : Rapport sur les comptes annuels - AGM 2021 | GRANT THORNTON ERNST & YOUNG et Autres
French member of Grant Thornton International
This is a t... | marketscre... |
11.12.2020 | Nanobiotix : Audit committee charter and internal rules of p... | NANOBIOTIX
AUDIT COMMITTEE
CHARTER
AND
INTERNAL RULES OF PROCEDURE
With the approval of the supervis... | marketscre... |
11.12.2020 | NANOBIOTIX
Nanobiotix : Audit committee charter and interna... | NANOBIOTIX
AUDIT COMMITTEE
CHARTER
AND
INTERNAL RULES OF PROCEDURE
With the approval of the supervis... | marketscre... |
23.10.2020 | NANOBIOTIX
Nanobiotix : announces third quarter 2020 revenu... | PRESS RELEASE
NANOBIOTIX ANNOUNCES THIRD QUARTER 2020 REVENUE
Paris, France; Cambridge, Massachusett... | marketscre... |
28.07.2020 | NANOBIOTIX
Nanobiotix : successfully raises approximatively... | PRESS RELEASE
NANOBIOTIX SUCCESSFULLY RAISES APPROXIMATELY €20 (US$24) MILLION IN PLACEMENT OF ORDIN... | marketscre... |
28.07.2020 | NANOBIOTIX
Nanobiotix : Successfully Raises Approximately ... | Regulatory News:
Not for release, publication or distribution, directly or indirectly, in or into th... | marketscre... |
27.07.2020 | NANOBIOTIX
Nanobiotix : raises approximately EUR 29.5 milli... | Not for release, publication or distribution, directly or indirectly, in or into the United States, ... | marketscre... |
08.06.2020 | Nanobiotix Secures €10M in Non-Dilutive Financing | PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--NANOBIOTIX (Paris:NANO), a clinical-stage nanomedicin... | citybizlis... |
16.10.2018 | Nanobiotix Receives First Tranche Disbursement of 16 Million... | ARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN: FR0011... | citybizlis... |
22.06.2018 | Nanobiotix shares rocket up on a marginal success for s... | → Shares of Nanobiotix (Euronext: NANO) soared after the biotech reported positive though mar... | endpts.com... |
06.07.2017 | Nanobiotix leverages physics to fight cancer | The 50-nanometer particles (50 billionths of a meter) are injected directly into tumors and absorbed... | medcitynew... |
13.12.2012 | Brainloop supports Major Licensing Deal for Nanobiotix with ... | Munich, Germany, 13 December 2012 – Brainloop announced today that French Nanobiotix S.A., a leader ... | realwire.c... |
03.05.2012 | Nanotherapeutic targets tumors in lung cancer patients, save... | Nanobiotix’s lead nanoXray therapeutic, NBTXR3, is injected into the tumor or the region of it and a... | medcitynew... |
03.05.2010 | Nanobiotix Raises $11M in Series C Financing Round | Nanobiotix, a Paris, France-based company wich develops innovative therapeutic products for cancer u... | finsmes.co... |
- | Nanotherapeutic targets tumors in lung cancer patients, save... | A French nanomedicine company developing a novel cancer therapeutic to strategically destroy tumors ... | medcitynew... |
- | Nanobiotix leverages physics to fight cancer | Radiation kills cancer cells, but it also takes healthy cells with them. The problem puts radiation ... | medcitynew... |